South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan

A person with diabetes mellitus (DM) has every right to perform the ritual of fasting during Ramadan. In daily practice we come across both type 1 and type 2 DM who wish to fast. This Consensus Statement describes the pre-Ramadan assessment, planning, prescription, management, and monitoring of pati...

Full description

Bibliographic Details
Main Authors:	Md Faruque Pathan, Rakesh Kumar Sahay, Abdul Hamid Zargar, Syed Abbas Raza, A K Azad Khan, Mohammed Ashraf Ganie, Nazrul Islam Siddiqui, Firoz Amin, Osama Ishtiaq, Sanjay Kalra
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2012-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	Aspart basal insulin detemir glargine lispro premixed insulin regular insulin type 1 diabetes type 2 diabetes
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=4;spage=499;epage=502;aulast=Pathan

Similar Items

Flexibility in insulin prescription
by: Sanjay Kalra, et al.
Published: (2016-01-01)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
by: Dippel, Franz-Werner, et al.
Published: (2010-01-01)

Análogos de insulina Insulin analogues
by: Manuel E. Licea Puig
Published: (2006-12-01)

High-mix insulins
by: Sanjay Kalra, et al.
Published: (2015-01-01)

Assessment of efficiency of application of various analogues of insulin in treatment of diabetes type 2
by: Rodionova T.l., et al.
Published: (2014-09-01)

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature
by: Ajay Kumar
Published: (2016-01-01)

Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
by: Karla F. S. Melo, et al.
Published: (2019-01-01)

CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
by: E. E. Arinina, et al.
Published: (2015-03-01)

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
by: Jakobsen Marie, et al.
Published: (2012-09-01)

Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A 1 chieve study
by: Subhash Kumar Wangnoo, et al.
Published: (2014-01-01)

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia
by: Sofie Broeng-Mikkelgaard, et al.
Published: (2023-11-01)

Forum for injection techniques, India: The first Indian recommendations for best practice in insulin injection technique
by: Sanjay Kalra, et al.
Published: (2012-01-01)

Choice of insulin in type 2 diabetes: A Southeast Asian perspective
by: Sanjay Kalra, et al.
Published: (2017-01-01)

Basal insulin titration algorithms in patients with type 2 diabetes: the simplest is the best (?)
by: V.I. Katerenchuk
Published: (2023-03-01)

Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
by: Sanjay Kalra, et al.
Published: (2016-01-01)

Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats
by: Yusaku Mori, et al.
Published: (2018-05-01)

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol
by: Sondra Davis, et al.
Published: (2017-04-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world
by: Zhang T, et al.
Published: (2018-07-01)

Basal Insulin Initiation in Elderly Patients with Type 2 Diabetes in Taiwan: A Comparison with Younger Patients
by: Ming-Nan Chien, et al.
Published: (2015-09-01)

Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015
by: Nikhil Tandon, et al.
Published: (2015-01-01)

Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
by: Shinje Moon, et al.
Published: (2021-09-01)

Predictors of Glycemic Response and Change in HbA1c Following Newly Initiated Basal Insulin Among Insulin Naïve Adults With Type 2 Diabetes
by: Mojtaba Malek, et al.
Published: (2017-10-01)

A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus
by: Marina V. Shestakova, et al.
Published: (2016-07-01)

Efficacy of Glargine Insulin Compared with Neutral Protamine Hagedorn Insulin in Patients with Type 2 Diabetes not Controlled with Oral Hypoglycemics: A Cohort Study
by: Ebtihal Bilal, et al.
Published: (2023-08-01)

Efficacy and safety of ultra-rapid lispro insulin in managing type-1 and type-2 diabetes: A systematic review and meta-analysis
by: Deep Dutta, et al.
Published: (2023-01-01)

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
by: Kress S, et al.
Published: (2021-03-01)

South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan
by: Md Faruque Pathan, et al.
Published: (2012-01-01)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
by: Trevor J. Orchard, et al.
Published: (2017-06-01)

The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real‐world data in Israel
by: Cheli Melzer Cohen, et al.
Published: (2020-07-01)

Case of subcutaneous insulin resistance syndrome treated with ultra‐rapid insulin lispro
by: Takahiro Ishii, et al.
Published: (2022-03-01)

Valutazione clinica e metabolica dell’impiego dell’insulina Lispro in pazienti con diabete mellito scompensato
by: Antonio Uneddu, et al.
Published: (2005-12-01)

Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
by: Yu Mi Kang, et al.
Published: (2019-08-01)

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01)

High concentration insulin
by: Sanjay Kalra
Published: (2018-01-01)

Maternal and neonatal outcomes with the use of long acting, compared to intermediate acting basal insulin (NPH) for managing diabetes during pregnancy: a systematic review and meta-analysis
by: Jijiao Wang, et al.
Published: (2022-10-01)

Treatment of Type 2 Diabetes with Biphasic Insulin Analogues
by: Ali A. Rizvi
Published: (2016-10-01)

Which people with diabetes are treated with a disposable, half‐unit insulin pen? A real‐world, retrospective, database study in Spain
by: F. Javier Ampudia‐Blasco, et al.
Published: (2023-11-01)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01)

Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
by: Han Na Jang, et al.
Published: (2019-12-01)